139 related articles for article (PubMed ID: 2794549)
1. Chronic cyclosporine-induced autoimmune disease in the rat: a new experimental model for scleroderma.
Bos GM; Majoor GD; Willighagen RG; van Breda Vriesman PJ
J Invest Dermatol; 1989 Nov; 93(5):610-5. PubMed ID: 2794549
[TBL] [Abstract][Full Text] [Related]
2. In vivo demonstration of microvascular pathology by intravital microscopy in experimental chronic graft-versus-host disease: analogy with scleroderma.
Bos G; Majoor G; Slaaf D; Reneman R; van Breda Vriesman P
J Rheumatol; 1988 Sep; 15(9):1339-45. PubMed ID: 3058970
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility and resistance to cyclosporin A-induced autoimmunity in rats.
Wodzig KW; Majoor GD; Van Breda Vriesman PJ
Autoimmunity; 1993; 16(1):29-37. PubMed ID: 8136464
[TBL] [Abstract][Full Text] [Related]
4. Murine sclerodermatous graft-versus-host disease, a model for human scleroderma: cutaneous cytokines, chemokines, and immune cell activation.
Zhang Y; McCormick LL; Desai SR; Wu C; Gilliam AC
J Immunol; 2002 Mar; 168(6):3088-98. PubMed ID: 11884483
[TBL] [Abstract][Full Text] [Related]
5. Cyclosporine-induced pseudo-graft-versus-host disease in the early post-cyclosporine period.
Beschorner WE; Shinn CA; Fischer AC; Santos GW; Hess AD
Transplantation; 1988 Aug; 46(2 Suppl):112S-117S. PubMed ID: 3043792
[TBL] [Abstract][Full Text] [Related]
6. T-cell maturation and clonal deletion in cyclosporine-induced autoimmunity.
Prud'homme GJ; Sanders R; Parfrey NA; Ste-Croix H
J Autoimmun; 1991 Apr; 4(2):357-68. PubMed ID: 1652970
[TBL] [Abstract][Full Text] [Related]
7. Effector mechanisms in cyclosporine A-induced syngeneic graft-versus-host disease. Role of CD4+ and CD8+ T lymphocyte subsets.
Hess AD; Fischer AC; Beschorner WE
J Immunol; 1990 Jul; 145(2):526-33. PubMed ID: 1973185
[TBL] [Abstract][Full Text] [Related]
8. Anti-TGF-beta treatment prevents skin and lung fibrosis in murine sclerodermatous graft-versus-host disease: a model for human scleroderma.
McCormick LL; Zhang Y; Tootell E; Gilliam AC
J Immunol; 1999 Nov; 163(10):5693-9. PubMed ID: 10553100
[TBL] [Abstract][Full Text] [Related]
9. Is chronic graft versus host disease an autoimmune disease?
Parkman R
Curr Opin Immunol; 1993 Oct; 5(5):800-3. PubMed ID: 8240743
[TBL] [Abstract][Full Text] [Related]
10. Similarity of scleroderma-like skin lesions in allogeneic and syngeneic bone marrow transplantation models.
Bos GM; Majoor GD; Slaaf DW; van de Gaar MJ; Weijmer-van Velzen JS; van Breda Vriesman PJ
Transplant Proc; 1989 Apr; 21(2):3262-3. PubMed ID: 2652812
[No Abstract] [Full Text] [Related]
11. Prevention of cyclosporine-induced syngeneic graft-versus-host disease in bone marrow transplantation by UV-B irradiated bone marrow cells.
Ohajekwe OA; James T; Hardy MA; Oluwole SF
Bone Marrow Transplant; 1995 Apr; 15(4):627-32. PubMed ID: 7655391
[TBL] [Abstract][Full Text] [Related]
12. Cyclosporin A induces a selective, reversible suppression of T-helper lymphocyte regeneration after syngeneic bone marrow transplantation: association with syngeneic graft-versus-host disease in rats.
Bos GM; Majoor GD; van Breda Vriesman PJ
Clin Exp Immunol; 1988 Dec; 74(3):443-8. PubMed ID: 2976623
[TBL] [Abstract][Full Text] [Related]
13. Is graft-versus-host disease a reliable model for scleroderma?
Mekori YA; Claman HN
Ric Clin Lab; 1986; 16(4):509-13. PubMed ID: 3576048
[TBL] [Abstract][Full Text] [Related]
14. Cyclosporin A-induced autoimmune disease in mice.
Bucy RP; Xu XY; Li J; Huang G
J Immunol; 1993 Jul; 151(2):1039-50. PubMed ID: 8335890
[TBL] [Abstract][Full Text] [Related]
15. Animal models of scleroderma.
Lakos G; Takagawa S; Varga J
Methods Mol Med; 2004; 102():377-93. PubMed ID: 15286396
[TBL] [Abstract][Full Text] [Related]
16. Arsenic trioxide prevents murine sclerodermatous graft-versus-host disease.
Kavian N; Marut W; Servettaz A; Laude H; Nicco C; Chéreau C; Weill B; Batteux F
J Immunol; 2012 May; 188(10):5142-9. PubMed ID: 22491256
[TBL] [Abstract][Full Text] [Related]
17. Syngeneic graft-versus-host disease after allogeneic bone marrow transplantation and cyclosporine treatment.
Hess AD; Vogelsang GB; Silanskis M; Friedman KA; Beschorner WE; Santos GW
Transplant Proc; 1988 Jun; 20(3 Suppl 3):487-92. PubMed ID: 3291285
[No Abstract] [Full Text] [Related]
18. Malignant neoplasms in cyclosporine-induced autoimmunity.
Wodzig KW; Majoor GD; Tiebosch AT; de Heer E; van Breda Vriesman PJ
Transplant Proc; 1993 Oct; 25(5):2816-8. PubMed ID: 8212246
[No Abstract] [Full Text] [Related]
19. Characterization of the pathogenic autoreactive T cells in cyclosporine-induced syngeneic graft-versus-host disease.
Chen W; Thoburn C; Hess AD
J Immunol; 1998 Dec; 161(12):7040-6. PubMed ID: 9862741
[TBL] [Abstract][Full Text] [Related]
20. Chronic graft-versus-host disease in rats after syngeneic bone marrow transplantation.
Oaks MK; Cramer DV
Transplantation; 1985 May; 39(5):504-10. PubMed ID: 3158105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
